| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06566755 | Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment… | Colorectal Cancer | Recruiting |
| Phase 2/3 | |||
| NCT05426486 | A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus… | HER2-positive Breast Cancer | Active, Not Recruiting |
| Not specified | |||
| NCT06881550 | Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in… | Breast Cancer | Enrolling by Invitation |
| NCT07512648 | Efficacy and Safety of Sanyong Jiedu Granules in Treating Lumps-Type Non-Lactational… | Plasmacytic Mastitis | Not Yet Recruiting |